Chemical structure of lovastatin
Find information on thousands of medical conditions and prescription drugs.

Lovastatin

Lovastatin is a member of the drug class of statins, used for lowering cholesterol and preventing cardiovascular disease (hypolipidemic agents). The mode of action of statins is HMG-CoA reductase enzyme inhibition. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
Labetalol
Lacrisert
Lactitol
Lactuca virosa
Lactulose
Lamictal
Lamisil
Lamivudine
Lamotrigine
Lanophyllin
Lansoprazole
Lantus
Lariam
Larotid
Lasix
Latanoprost
Lescol
Letrozole
Leucine
Leucovorin
Leukeran
Levaquin
Levetiracetam
Levitra
Levocabastine
Levocetirizine
Levodopa
Levofloxacin
Levomenol
Levomepromazine
Levonorgestrel
Levonorgestrel
Levophed
Levora
Levothyroxine sodium
Levoxyl
Levulan
Lexapro
Lexiva
Librium
Lidocaine
Lidopen
Linezolid
Liothyronine
Liothyronine Sodium
Lipidil
Lipitor
Lisinopril
Lithane
Lithobid
Lithonate
Lithostat
Lithotabs
Livostin
Lodine
Loestrin
Lomotil
Loperamide
Lopressor
Loracarbef
Loratadine
Loratadine
Lorazepam
Lortab
Losartan
Lotensin
Lotrel
Lotronex
Lotusate
Lovastatin
Lovenox
Loxapine
LSD
Ludiomil
Lufenuron
Lupron
Lutropin alfa
Luvox
Luxiq
Theophylline
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Lovastatin was isolated from a strain of Aspergillus terreus and it was the first statin approved by the FDA (August 1987).

Lovastatin is also naturally produced by certain higher fungii such as Pleurotus ostreatus (oyster mushroom) and closely related Pleurotus spp. (Bobek et al., 1998)

In 1998, the US FDA placed a ban on the sale of dietary supplements derived from red yeast rice, which naturally contains lovastatin, arguing that products containing prescription agents require drug approval.

Brand names

  • Mevacor®
  • Advicor® (as a combination with niacin)
  • Altocor®
  • Altoprev®

Reference

  • Bobek P, Ozdin L, Galbavy S. Dose- and time-dependent hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rats. Nutrition 1998;14:282-6. PMID 9583372.


Read more at Wikipedia.org


[List your site here Free!]


Cholesterol-lowering diet vs. treatment with lovastatin - Tips from Other Journals
From American Family Physician, 2/1/04 by Caroline Wellbery

Efforts to lower cholesterol through dietary manipulations have had only modest effects. In an attempt to increase the efficacy of diet in the prevention of cardiovascular disease, the Adult Treatment Panel of the National Cholesterol Education Program has recommended adding plant sterols and viscous fibers to the diet. Soy proteins and nuts may have additional health benefits. Jenkins and colleagues examined the cholesterol-lowering potential of a diet low in saturated-fat that included these ingredients.

Forty-six healthy adults with hyperlipidemia completed the four-week study. All participants followed their own diet that was low in saturated fat for one month before the start of the study. They were then randomized into one of the following groups: a very-low-saturated-fat diet without a statin; the same diet with a statin; or a similar diet with added viscous fibers, plant sterols, soy foods, and almonds. Weight, blood pressure, and menu checklists were reviewed at regular intervals. Patients reported their satiety levels on a weekly basis.

All diets were vegetarian, and the intervention diet containing soy foods, viscous fiber, plant sterols, and almonds also included eggs and butter to balance the saturated fat and dietary cholesterol content of the control (non-statin) diet.

Compliance with the prescribed diets was at least 93 percent in all three groups, and all participants reported adequate satiety. At baseline, all three groups had similar blood measurements, including low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and C-reactive protein levels. After four weeks, the control group lowered their LDL-C by 8 percent, increased the LDL-C to HDL-C ratio by 3 percent, and lowered the C-reactive protein level by 10 percent.

The group receiving a statin lowered their LDL-C by 30.9 percent, decreased the LDL-C to HDL-C ratio by 28.4 percent, and lowered the C-reactive protein level by 33.3 percent. The intervention-diet group lowered their LDL-C by 28.6 percent, decreased the LDL-C to HDL-C ratio by 23.5 percent, and lowered the C-reactive protein level by 28.2 percent. The reductions in blood lipid levels in the statin and dietary intervention groups were significantly greater than were the changes in the control group for total cholesterol, LDL-C, apolipoprotein B, and the ratios of total cholesterol to HDL-C, LDL-C to HDL-C, and apolipoprotein B to apolipoprotein A1, with no significant differences between the statin group and the intervention diet group.

Similarly, C-reactive protein levels were significantly lower in both the intervention-diet group and the statin group than in the control group, with no differences between the intervention-diet group and the statin group. The authors conclude that diet alone, if selecting for foods with cholesterol-lowering properties, can lower cholesterol as well as statins.

Jenkins DJ, et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA July 23/30, 2003;290:502-10.

COPYRIGHT 2004 American Academy of Family Physicians
COPYRIGHT 2004 Gale Group

Return to Lovastatin
Home Contact Resources Exchange Links ebay